AI assistant
NEOGENOMICS INC — Director's Dealing 2017
May 31, 2017
32227_dirs_2017-05-30_91298f45-4933-4345-8175-a134a4f1150d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2017-05-25
Reporting Person: TETRAULT LYNN A. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-30 | Common Stock | M | 7222 | $0.00 | Acquired | 21782 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-30 | Restricted Stock | $ | C | 2150 | Disposed | 2017-03-31 | Common Stock (2150) | Direct |
| 2017-05-30 | Restricted Stock | $ | C | 5072 | Disposed | 2017-03-31 | Common Stock (5072) | Direct |
| 2017-05-25 | Stock Option (Right to Buy) | $7.27 | A | 10000 | Acquired | 2022-05-25 | Common Stock (10000) | Direct |
| 2017-05-25 | Restricted Stock | $ | A | 8667 | Acquired | Common Stock (8667) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 14560 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $4.78 | 2020-07-15 | Common Stock (10000) | 10000 | Direct |
| Stock Option (Right to Buy) | $9.11 | 2021-07-28 | Common Stock (8333) | 8333 | Direct |
Footnotes
F1: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
F2: Restricted stock has vested and restricted stock certificate issued for shares of the company's common stock.
F3: 537.5 shares will vest on June 30, 2016 and thereafter, 537.5 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2017.
F4: 1,690.6 shares will vest on September 30, 2016 and thereafter, 1,690.7 shares will vest on the last day of each calendar quarter for the next two fiscal quarters up to March 31, 2017.
F5: On July 15, 2015, Lynn Tetrault was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.
F6: On July 28, 2016, Lynn Tetrault was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F7: On May 25, 2017, Lynn Tetrault was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.
F8: The restricted stock will vest as follows; 2,166 units at June 30, 2017 and thereafter, 2,167 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2018.
F9: These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date.